AZN - Spark Newswire

1 minute read

AstraZeneca’s Koselugo Gets European Nod To Treat Children With Multisystem Genetic Disorder

Today, 2:29 PM

European Union has approved AstraZeneca plc’s (NASDAQ:AZN) Koselugo to treat children with neurofibromatosis type 1 and plexiform neurofibromas. Neurofibromatosis type…

AZN

1 minute read

Dual-Antibody Cocktail Shows Effectiveness In COVID-19 Animal Models: Reuters

By Vandana Singh

Today, 2:29 PM

In mice and hamster study, COVID-19 therapies comprising two types of antibodies were found to be effective against…

ABBV

3 minute read

AstraZeneca Announced Koselugo Approved in the EU for Children with NF1

By Charles Gross

Today, 2:29 PM

AstraZeneca (NYSE: AZN) and MSD's (NYSE: MRK) Koselugo (selumetinib) has been granted conditional approval in the European Union (EU) for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in paediatric patients with neurofibromatosis type 1 (

AZN

1 minute read

Court Rules In Favor Of AstraZeneca Over Delay In COVID-19 Shot Deliveries

By Vandana Singh

Today, 2:29 PM

AstraZeneca Plc (NASDAQ:AZN) claims victory in a court tussle with the European Union over allegations that the company was not producing…

AZN

1 minute read

News
Rumors

Serum Institute of India to Increase AstraZeneca COVID-19 Vaccine Production from 90M to 100M Doses/Month or More Starting July

By Charles Gross

Today, 2:29 PM

-Reuters https://news.trust.org/item/20210617074106-0k7ka/

AZN

1 minute read

Novavax COVID-19 Vaccine Could Become Available In India By September, Says Partner

By Rachit Vats

Today, 2:29 PM

Novavax Inc (NASDAQ: NVAX) COVID-19 vaccine, marketed as "Covovax," could see a launch in India as early as September, Moneycontrol

AZN

6 minute read

The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda

By Shanthi Rexaline

Today, 2:29 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14)

ACHL

1 minute read

Fusion Pharma’s Stock Moves Higher As Radiopharmaceutical Candidate Shows Early Promising Action In Solid Tumor Study

By Vandana Singh

Today, 2:29 PM

Fusion Pharmaceuticals Inc (NASDAQ:FUSN) has announced preliminary Phase 1 data from the single-dose portion of the study evaluating FPI-1434 in patients…

AZN